PROTAGENIC THERAPEUTICS
PTIXPerformance Technologies Inc (PTIX) specializes in developing and integrating networking, communications, and multimedia technology solutions for defense, aerospace, and commercial markets. The company focuses on systems that support high-speed data, voice, and video communications, offering hardware, software, and engineering services to enable secure and reliable connectivity.
Company News
Gainers DiamondHead Holdings Corp. (NASDAQ: DHHC) shares jumped 104.2% to $21.15. DiamondHead entered into convertible note purchase agreement dated March 21, 2023. Boxed, Inc. (NYSE: BOXD) gained 59.1% to $0.2862 after gaining around 50% on Wednesday. Boxed recently said it is evaluating potentially filing for relief under the U.S. Bankruptcy ...
Gainers Dermata Therapeutics, Inc. (NASDAQ: DRMA) shares jumped 121% to $0.4428 after the company requested to withdraw its registration on Form S-1 and said it does not intend to pursue the contemplated public offering. Palisade Bio, Inc. (NASDAQ: PALI) shares jumped 80.1% to $5.80. Palisade Bio announced $2.5 million registered direct offering...
Scientific rationale and evidence for PT00114 in the treatment of Depression, Anxiety, PTSD and Addiction to be discussed
NEW YORK, Aug. 17, 2021 (GLOBE NEWSWIRE) -- Protagenic Therapeutics, Inc. (Nasdaq: PTIX) a biopharmaceutical company focused on developing therapies to treat stress-related neurologic disorders, today announced results for the second quarter ended June 30, 2021.
NEW YORK, July 23, 2021 (GLOBE NEWSWIRE) -- Protagenic Therapeutics, Inc. (Nasdaq: PTIX) a biopharmaceutical company focused on developing therapies to treat stress-related neurologic disorders, today announced that upon reviewing its investigational new drug (IND) application filed on June 29th, the U.S. Food and Drug Administration (FDA) has ...
